about
Exercise responsive genes measured in peripheral blood of women with chronic fatigue syndrome and matched control subjectsMyalgic encephalomyelitis/chronic fatigue syndrome and encephalomyelitis disseminata/multiple sclerosis show remarkable levels of similarity in phenomenology and neuroimmune characteristicsMicrobial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis.The debate: myalgic encephalomyelitis and chronic fatigue syndrome.Effects of Sleep Fragmentation and Chronic Latent Viral Infection on Behavior and Inflammation in Mice.Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome.MicroRNAs hsa-miR-99b, hsa-miR-330, hsa-miR-126 and hsa-miR-30c: Potential Diagnostic Biomarkers in Natural Killer (NK) Cells of Patients with Chronic Fatigue Syndrome (CFS)/ Myalgic Encephalomyelitis (ME)Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?Diagnostic and treatment challenges of chronic fatigue syndrome: role of immediate-release methylphenidate.Effects of Chronic Diurnal Disruption and Acute Inflammatory Challenge on Mice with Latent Murine Gammaherpesvirus Infection.Use of single-nucleotide polymorphisms (SNPs) to distinguish gene expression subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME).Mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways.Hypothalamic involvement assessed by T1 relaxation time in patients with relapsing-remitting multiple sclerosis.Identifying illness parameters in fatiguing syndromes using classical projection methods.Chronic fatigue syndrome/myalgic encephalomyelitis: an update.Anti-Fatigue Effects of the Unique Polysaccharide Marker of Dendrobium officinale on BALB/c Mice.
P2860
Q24522299-7C1E5378-188D-4BB9-9518-48FCD0A6BEB4Q26998412-0B2A6921-8162-49F2-BEEC-99D1ED482647Q34064398-CDD6F04A-5956-436D-8373-1F9A431EFEA0Q34546727-85D770FE-43D8-4FDB-9666-234ED6DE232BQ35798450-36D76888-AC05-48E5-B2E6-BAF357568A4FQ35953947-A70C559E-3C7A-4B74-809B-ABC58816EF86Q35954084-90485ADA-2D0F-42D5-B7CA-10EB47AA7344Q36226201-0E5E2AC1-AA1E-46D3-A29F-249386E903B9Q37174049-BDD2030B-816E-4175-B0DD-1A3EF9AB7B36Q37505870-132C9960-30DD-492E-A69B-A642C7F50827Q44958259-5115C81C-D35D-4A40-B971-75784AD75739Q46929110-F6C07CCA-BC48-4CA3-B7E0-3E6C62764049Q48378854-70D6DA58-B005-461C-A22A-16B7B3729142Q48505258-83DBB0C7-3E01-4340-A4EB-6B0F129385A2Q51515704-B61E152D-4844-42AD-B3FE-341F6918F548Q52923560-AA5E8FBA-FEE5-4E84-A6E3-57F164AD1108
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neuroendocrine aspects of chronic fatigue syndrome.
@ast
Neuroendocrine aspects of chronic fatigue syndrome.
@en
type
label
Neuroendocrine aspects of chronic fatigue syndrome.
@ast
Neuroendocrine aspects of chronic fatigue syndrome.
@en
prefLabel
Neuroendocrine aspects of chronic fatigue syndrome.
@ast
Neuroendocrine aspects of chronic fatigue syndrome.
@en
P2093
P356
P1476
Neuroendocrine aspects of chronic fatigue syndrome.
@en
P2093
Alexandros N Vgontzas
Anthony Kales
Clare H Newbrand
Dimitris A Papanicolaou
Donald W Pfaff
George C Tsokos
Glen Allen
Jay D Amsterdam
Rebecca C Moore
Rosane Nisenbaum
P356
10.1159/000075315
P577
2004-01-01T00:00:00Z